Drug Discovery Today, Journal Year: 2024, Volume and Issue: 29(7), P. 104019 - 104019
Published: May 8, 2024
Language: Английский
Drug Discovery Today, Journal Year: 2024, Volume and Issue: 29(7), P. 104019 - 104019
Published: May 8, 2024
Language: Английский
Journal of Materials Chemistry B, Journal Year: 2024, Volume and Issue: 12(37), P. 9111 - 9143
Published: Jan. 1, 2024
The unique roles of nanozymes in enhancing immunotherapy through disrupting tumor metabolism and mediating combination therapies.
Language: Английский
Citations
2Acta Naturae, Journal Year: 2023, Volume and Issue: 15(1), P. 4 - 12
Published: May 3, 2023
The problem of low efficiency nanotherapeutic drugs challenges the creation new alternative biomedical nanosystems known as robotic nanodevices. In addition to encapsulating properties, nanodevices can perform different functions, such precision surgery, in vivo detection and imaging, biosensing, targeted delivery, and, more recently, detoxification endogenous xenobiotic compounds. Nanodevices for are aimed at removing toxic molecules from biological tissues, using a chemical- and/or enzyme-containing nanocarrier toxicant diffuse inside nanobody. This strategy is opposite drug delivery systems that focus on releasing them under influence external factors. review describes various kinds intended differ by type poisoning treatment they provide, well materials toxicants. final part devoted enzyme nanosystems, an emerging area research provides fast effective neutralization toxins vivo.
Language: Английский
Citations
5Journal of Analysis and Testing, Journal Year: 2023, Volume and Issue: 7(3), P. 215 - 226
Published: Sept. 1, 2023
Language: Английский
Citations
4Journal of Nanobiotechnology, Journal Year: 2024, Volume and Issue: 22(1)
Published: May 6, 2024
Abstract Background Elevated interstitial fluid pressure within tumors, resulting from impaired lymphatic drainage, constitutes a critical barrier to effective drug penetration and therapeutic outcomes. Results In this study, based on the photosynthetic characteristics of algae, an active carrier (CP@ICG) derived Chlorella pyrenoidos (CP) was designed constructed. Leveraging hypoxia tropism phototropism exhibited by CP, we achieved targeted transport tumor sites. Additionally, dual near-infrared (NIR) irradiation at site facilitated photosynthesis in enabling breakdown excessive intratumoral generating oxygen water decomposition. This process effectively reduced pressure, thereby promoting enhanced perfusion blood into tumor, significantly improving deep-seated chemotherapeutic agents, alleviating hypoxia. Conclusions CP@ICG demonstrated combined effect photothermal/photodynamic/starvation therapy, exhibiting excellent vitro/in vivo anti-tumor efficacy favorable biocompatibility. work provides scientific foundation for application microbial-enhanced delivery therapy. Graphical
Language: Английский
Citations
1Drug Discovery Today, Journal Year: 2024, Volume and Issue: 29(7), P. 104019 - 104019
Published: May 8, 2024
Language: Английский
Citations
1